Challenge of Allergan tribal patent deal in uncharted legal territory

(Reuters) - As generic drug manufacturers are gearing up to argue that a deal Allergan Plc made with a Native American tribe to shield patents from administrative review is a sham, some experts say the generic companies are in uncharted legal territory.